Essex Investment Management CO LLC Gilead Sciences, Inc. Transaction History

Essex Investment Management CO LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $1.81 Million - $2.05 Million	-27,822 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $5,753 - $6,207	85 Added 0.31%	27,822 $1.94 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $143,823 - $157,147	-2,266 Reduced 7.55%	27,737 $1.91 Million
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $129,780 - $148,078	-2,163 Reduced 6.72%	30,003 $1.94 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $375,306 - $427,643	-6,625 Reduced 17.08%	32,166 $1.87 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $37,197 - $46,769	-599 Reduced 1.52%	38,791 $2.45 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $103,373 - $120,036	-1,429 Reduced 3.5%	39,390 $3.03 Million
Q1 2020 May 04, 2020	BUY	$62.63 - $80.22 $2.56 Million - $3.27 Million	40,819 New	40,819 $3.05 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $1.85 Million - $2.41 Million	-30,553 Closed	0 $0
Q3 2018 Oct 16, 2018	SELL	$71.28 - $78.92 $2.03 Million - $2.24 Million	-28,434 Reduced 48.2%	30,553 $2.36 Million
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $12,521 - $14,606	-193 Reduced 0.33%	58,987 $4.18 Million
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $2.56 Million - $3.12 Million	35,080 Added 145.56%	59,180 $4.46 Million
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $3.83 Million - $4.49 Million	-53,766 Reduced 69.05%	24,100 $1.73 Million
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $5.61 Million - $6.66 Million	77,866	77,866 $6.31 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.